The main purpose of this study is to begin to collect information and try to learn whether
SU011248 works in treating patients with advanced liver cancer. Laboratory studies have shown
that SU011248 may block the growth of blood vessels in tumors, which may prevent tumors from
growing any further.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Dana-Farber Cancer Institute